{"version":"1.0","type":"rich","provider_name":"techandbusiness.org","provider_url":"https://techandbusiness.org","title":"QUANTRO receives Austrian grant to develop AI drug discovery platform","author_name":"techandbusiness.org · AI, Tech & Business","thumbnail_url":"https://manilatimes.net/manilatimes/uploads/images/2026/11/03/1289717.png","width":600,"height":400,"html":"<blockquote class=\"tb-newswire-embed\" style=\"max-width:600px;border-left:3px solid #22d3ee;padding:12px 16px;margin:0;font-family:-apple-system,system-ui,sans-serif;background:#09090b;border-radius:0 8px 8px 0;\">\n      <p style=\"margin:0 0 8px;font-size:10px;font-weight:600;letter-spacing:0.1em;color:#71717a;\">techandbusiness.org · AI, Tech & Business</p>\n      <p style=\"margin:0 0 8px;font-size:18px;font-weight:700;line-height:1.3;color:#fff;\"><a href=\"https://techandbusiness.org/newswire/j4tsjOAo-L8jx09SNBVl8P\" style=\"color:#fff;text-decoration:none;\">QUANTRO receives Austrian grant to develop AI drug discovery platform</a></p>\n      <p style=\"margin:0;font-size:14px;color:#a1a1aa;line-height:1.5;\">QUANTRO Therapeutics said it received a 12-month, non-dilutive research grant from Austria's Research Promotion Agency to develop ASCEND, an AI platform for discovering drugs that target transcription factors, proteins that regulate gene expression....</p>\n    </blockquote>"}